π
|
Sotatercept for the Treatment of Pulmonary Arterial Hypertension.
18 auth.
M. Humbert,
V. McLaughlin,
J. Gibbs,
M. Gomberg-Maitland,
M. Hoeper,
I. Preston,
R. Souza,
A. Waxman,
P. Escribano SubΓas,
J. Feldman,
...
G. Meyer,
D. Montani,
K. Olsson,
S. Manimaran,
J. Barnes,
P. Linde,
J. de Oliveira Pena,
D. Badesch
|
7 |
2021 |
7 π
|
π
|
PULSAR: A phase 2, randomized, double-blind, placebo-controlled study to assess the efficacy and safety of sotatercept (ACE-011) when added to standard of care (SOC) for treatment of pulmonary arterial hypertension (PAH)
12 auth.
D. Badesch,
S. Gibbs,
M. Gomberg-Maitland,
M. Humbert,
V. McLaughlin,
I. Preston,
...
R. Souza,
A. Waxman,
J. Pena,
J. Barnes,
Xioasha Zhang,
R. Zeldin
|
2 |
2019 |
2 π
|
π
|
PULSAR Study Open-Label Extension: Interim Results from a Phase 2 Study of the Efficacy and Safety of Sotatercept When Added to Standard of Care for the Treatment of Pulmonary Arterial Hypertension (PAH)
12 auth.
D. Badesch,
S. Gibbs,
M. Gomberg-Maitland,
M. Hoeper,
V. Mclaughlin,
I. Preston,
...
R. Souza,
A. Waxman,
S. Manimaran,
J. Barnes,
J. de Oliveira Pena,
M. Humbert
|
1 |
2021 |
1 π
|
π
|
PULSAR open-label extension: interim results from a phase 2 study of the efficacy and safety ofΒ sotatercept when added to standard of care for the treatment of pulmonary arterial hypertension (PAH)
13 auth.
D. Badesch,
S. Gibbs,
M. Gomberg-Maitland,
M. Hoeper,
V. McLaughlin,
I. Preston,
R. Souza,
A. Waxman,
S. Manimaran,
J. Barnes,
...
J. de Oliveira Pena,
M. Humbert,
M. Hoeper
|
0 |
2021 |
0 π
|